Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Contrast-induced Nephropathy in Angiography
NCT02761577Phase 4Completed
- Sponsor
- Clinical Hospital Center Zagreb
- Start
- Jun 2012
- Primary completion
- Jul 2013
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
A Phase 4 trial of sodium bicarbonate ringer's solution, acetylcysteine in contrast-induced nephropathy (CIN), sponsored by Clinical Hospital Center Zagreb. Started Jun 2012; status: completed.
02
Drugs
sodium bicarbonate ringer's solutionacetylcysteine
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT02761577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02761577.